Evidence map›Paper›PMID 32405705›Full record

ReviewCellular and molecular neurobiology2021

Cardiac Neural Crest Cells: Their Rhombomeric Specification, Migration, and Association with Heart and Great Vessel Anomalies.

Olivier Schussler, Lara Gharibeh, Parmeseeven Mootoosamy, Nicolas Murith, Vannary Tien, Anne-Laure Rougemont, Tornike Sologashvili, Erik Suuronen, Yves Lecarpentier, Marc Ruel

Open access · greenAbstract readReview
In one paragraph

Review in Cellular and molecular neurobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. First quantitative dosages: Strong correlations between non-5-HTFrontiers in cardiovascular medicine · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. The Progress of Stem Cell Technology for Skeletal Regeneration.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Olivier Schussler *Department of Cardiovascular Surgery Adult and Pediatric, Geneva University Hospital, Geneva, Switzerland. olivier.schussler@gmail.com.ORCID http://orcid.org/0000-0002-5394-8175
Lara Gharibeh *Molecular Genetics and Cardiac Regeneration Laboratory, Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, Canada.
Parmeseeven MootoosamyDepartment of Cardiovascular Surgery Adult and Pediatric, Geneva University Hospital, Geneva, Switzerland.
Nicolas MurithDepartment of Cardiovascular Surgery Adult and Pediatric, Geneva University Hospital, Geneva, Switzerland.
Vannary TienDepartment of Pathology and Immunology, Faculty of Medicine of the University of Geneva, Geneva, Switzerland.
Anne-Laure RougemontDivision of Clinical Pathology, Geneva University Hospital, Geneva, Switzerland.
Tornike SologashviliDepartment of Cardiovascular Surgery Adult and Pediatric, Geneva University Hospital, Geneva, Switzerland.
Erik SuuronenDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.
Yves LecarpentierGrand Hopital de l'Est Francilien, Meaux, France.
Marc RuelDepartment of Cardiovascular Surgery, University of Ottawa Heart Institute and School of Epidemiology, Ottawa, ON, Canada.
University Hospital of Geneva · CHUniversity of Ottawa · CAUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Outflow tract abnormalities are the most frequent congenital heart defects. These are due to the absence or dysfunction of the two main cell types, i.e., neural crest cells and secondary heart field cells that migrate in opposite directions at the same stage of development. These cells directly govern aortic arch patterning and development, ascending aorta dilatation, semi-valvular and coronary artery development, aortopulmonary septation abnormalities, persistence of the ductus arteriosus, trunk and proximal pulmonary arteries, sub-valvular conal ventricular septal/rotational defects, and non-compaction of the left ventricle. In some cases, depending on the functional defects of these cells, additional malformations are found in the expected spatial migratory area of the cells, namely in the pharyngeal arch derivatives and cervico-facial structures. Associated non-cardiovascular anomalies are often underestimated, since the multipotency and functional alteration of these cells can result in the modification of multiple neural, epidermal, and cervical structures at different levels. In most cases, patients do not display the full phenotype of abnormalities, but congenital cardiac defects involving the ventricular outflow tract, ascending aorta, aortic arch and supra-aortic trunks should be considered as markers for possible impaired function of these cells. Neural crest cells should not be considered as a unique cell population but on the basis of their cervical rhombomere origins R3-R5 or R6-R7-R8 and specific migration patterns: R3-R4 towards arch II, R5-R6 arch III and R7-R8 arch IV and VI. A better understanding of their development may lead to the discovery of unknown associated abnormalities, thereby enabling potential improvements to be made to the therapeutic approach.

Indexed as

Cell MovementAnimalsBlood VesselsBody PatterningHumansMicroRNAsMyocardiumNeural CrestMicroRNAsAnomaliesArterial poleCardiac neural crestHeartNeural crest cellsOutflow tract developmentRhombomeric specification

Identifiers

PMID32405705
PMCPMC11448677
OpenAlexW3024034462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.